Company Filing History:
Years Active: 2012
Title: Sebastian Raimundo: Innovator in Pharmacogenomics
Introduction
Sebastian Raimundo is a prominent inventor based in Stuttgart, Germany. He has made significant contributions to the field of pharmacogenomics, particularly through his research on the CYP2D6 gene. His work focuses on understanding how genetic variations can influence drug metabolism and response in individuals.
Latest Patents
Sebastian holds a patent titled "Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications." This patent includes polynucleotides of molecular variant promoters of the CYP2D6 gene, which are associated with abnormal drug responses or individual predispositions to various common diseases and disorders. The patent describes methods for diagnosing the status of disorders related to drug metabolization and provides kits that include oligonucleotides useful for identifying subjects who are ultrarapid or intermediate metabolizers of drugs.
Career Highlights
Sebastian is currently associated with Pgxhealth, LLC, where he continues to advance research in pharmacogenomics. His work has the potential to significantly impact personalized medicine by improving drug therapy outcomes based on genetic profiles.
Collaborations
Sebastian collaborates with Ulrich Zanger, a fellow researcher in the field. Their combined expertise enhances the understanding of drug metabolism and its implications for patient care.
Conclusion
Sebastian Raimundo's innovative work in pharmacogenomics exemplifies the importance of genetic research in improving drug therapies. His contributions are paving the way for advancements in personalized medicine and better health outcomes for patients.